Q4 2013, report

Q4 HIGHLIGHTS

  • Governmental grant for new pilot research project, in line with growth strategy.
  • New Mammo 2 product successfully launched at RSNA.
  • New product configuration for Ultrasound Point-of-Care.

Q4 FINANCIAL DATA

  • Sales of 15.5 MSEK (20.5).
  • Operating result of 3.7 MSEK (1.6) and operating margin of 23.7% (7.8%).
  • Earnings per share of 0,37 (0,20) SEK.

Please find the report here.

A video presentation by CEO Anita Tollstadius will follow on Friday February 21, at 9.00 CET.

Please follow the link: webbtv.nu/contextvisionq42013